(A) Basal ROS levels among BJ-derived cell lines were compared (n = 8).
(B) The growth inhibition effect of antioxidant-targeting compounds was determined in the four BJ-derived cells (n = 3). The bar graph indicates growth inhibition at two different concentrations (2× GI50 and 4× GI50 for each compound in BJeLR cells).
(C) Other antioxidant inhibitors do not deplete GSH during cell death (n = 3).
(D) Erastin depletes cellular GSH equally in the four BJ-derived cell lines.
(E) GSH-depleting reagents elevated both cytosolic and lipid ROS level, whereas other antioxidant inhibitors did not (n = 3).
(F) GSH-depleting reagents (ERA and BSO) inhibited GPX activity. Rel. Abs., relative absorbance.
n.s., not significant; *p < 0.05; ***p < 0.001. Error bars in (B), (C), and (E) represent mean ± SD. See also Figure S2.